LambdaVision is developing a protein-based artificial retina to restore meaningful vision for the millions of patients blinded by retinal degenerative diseases.
Location: United States
Employees: 11-50
Phone: +1 860-679-2558
Total raised: $7.54M
Founded date: 2009
Investors 5
| Date | Name | Website |
| - | Connecticu... | ctinnovati... |
| - | Aurelia Fo... | aureliafou... |
| 10.07.2026 | Band of An... | bandangels... |
| - | MassChalle... | masschalle... |
| - | FirstXFoun... | firstxfoun... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 06.11.2025 | Seed | $7M | Seraphim |
| 18.10.2017 | Series A | $500K | - |
| 03.10.2011 | Pre-Seed | $40K | - |
Mentions in press and media 10
| Date | Title | Description |
| 07.11.2025 | LambdaVision Secures $7M for Space-Based Vision Restoration | LambdaVision, a pioneering biotech firm, secured $7 million in seed funding. The company leverages microgravity on the International Space Station to manufacture advanced protein-based artificial retinas. This breakthrough technology target... |
| 06.11.2025 | LambdaVision: $7 Million Seed Round Raised To Advance Space-Based Artificial Retina Manufacturing | LambdaVision, a biotechnology company developing a protein-based artificial retina to restore vision for patients affected by retinal degenerative diseases, announced it has raised $7 million in seed funding. The round was co-led by Seven S... |
| 05.11.2025 | LambdaVision Raises $7M in Seed Funding | LambdaVision, a Woodbridge, CT-baserd biotech company leveraging microgravity to manufacture investigational protein-based artificial retina, raised $7M in Seed funding. The round was led by Seven Seven Six and Aurelia Foundry Fund, with ad... |
| 05.11.2025 | LambdaVision Banks $7M Seed Round | WOODBRIDGE, CT, LambdaVision, a biotech innovator has closed a $7M seed funding round co-led by Seven Seven Six and Aurelia Foundry Fund. >> Click here for more funding data on LambdaVision >> To export LambdaVision funding dat... |
| 29.05.2024 | LambdaVision Holds First Closing of Seed Funding | LambdaVision, a CT-based biotech company developing a protein-based artificial retina technology, closed its first Seed funding. The round was led by Aurelia Foundry Fund, a fund spun out of MIT. Other investors included Boryung, a publicly... |
| 18.10.2017 | LambdaVision Snares $500K in Series A Equity | FARMINGTON, CT, UConn spinout today announced that it was awarded $500,000 in Series A Equity from Connecticut Innovations. >> Click here for more funding data on LambdaVision >> To export LambdaVision funding data to PDF an... |
| 03.11.2016 | MassChallenge Boston Awards $1.5M in Zero-Equity Prizes to Top Startups | The seventh-annual MassChallenge Boston Awards brought together more than 1,500 leaders and supporters from the Boston entrepreneurial community to celebrate the MassChallenge entrepreneurs at the Boston Convention and Exhibition Center. Th... |
| 03.10.2011 | LambdaVision Sees $40K Pre-Seed Round | The financing will be used to conduct proof-of-concept studies, to validate the use of an ion-mediated artificial retina for restoring sight. LambdaVision has secured required matching funds from the University of Connecticut Research and... |
| - | Artificial Retinas Manufactured in Orbit Show Superior Results, Offering New Hope for Incurable Vision Loss | Connecticut-based biotech LambdaVision has spent nearly a decade turning the International Space Station (ISS) into its primary manufacturing floor. The company has developed an artificial retina, which is assembled from hundreds of alterna... |
| - | LambdaVision | “LambdaVision, Inc.” |